A worldwide presence
AAA operates in Belgium, Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, UK and USA while its distribution network covers more than 30 countries. Please point to any of the locations to pull up specific details about each facility.Read More
Advanced Accelerator Applications (AAA) develops, produces and commercializes molecular nuclear medicine, diagnostic and therapeutic products in the fields of oncology (cancer), neurology, cardiology and infectious & inflammatory diseases.Read More
Our most advanced investigational product candidates in development are 177Lutetium Dotatate, and Annexin V-128. 177Lutetium Dotatate is an investigational Molecular Nuclear Therapy candidate.Read More
Molecular Nuclear Medicine
Making personalised treatment a reality.
AAA is a European leader in the production and commercialization of PET (Positron Emission Tomography) and SPECT (Single Photon Emission Tomography) radiopharmaceuticals and is able to produce and deliver both commercial drugs and research products.
Our documentary about Molecular Nuclear Medicine and cancer.
Molecular Nuclear Medicine with a 22’ documentary from the history of radioactivity and cancer to the most modern Theragnostic techniques. You will understand how SPECT and PET work, and how Radio Metabolic Therapy can treat cancer.